Aci Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 05-07-2024
- Paid Up Capital ₹ 0.10 M
as on 05-07-2024
- Company Age 21 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 8.91%
(FY 2019)
- Profit 81.02%
(FY 2019)
- Ebitda 103.07%
(FY 2019)
- Net Worth -3.92%
(FY 2019)
- Total Assets -6.66%
(FY 2019)
About Aci Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Priti Chetan, Kartik Sahay, and Bharti Sahay serve as directors at the Company.
- CIN/LLPIN
U24239DL2003PTC119266
- Company No.
119266
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Mar 2003
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
East Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Aci Pharma Private Limited offer?
Aci Pharma Private Limited offers a wide range of products and services, including Essential & Aromatic Oils, Carrier Oil, Pharma Ingredients & Raw Materials, Antipyretic and Analgesic API.
Who are the key members and board of directors at Aci Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kartik Sahay  | Director | 22-Nov-2004 | Current |
Priti Chetan  | Additional Director | 17-Sep-2021 | Current |
| Bharti Sahay | Director | 01-Apr-2008 | Current |
Financial Performance and Corporate Structure Insights of Aci Pharma.
Aci Pharma Private Limited, for the financial year ended 2019, experienced modest growth in revenue, with a 8.91% increase. The company also saw a substantial improvement in profitability, with a 81.02% increase in profit. The company's net worth dipped by a decrease of 3.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aci Pharma?
In 2019, Aci Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Applied Electrical And Mechanical Technology Private Limited
Active
7 months 23 days Priti Chetan and Kartik Sahay are mutual person
Krishka Foods Private Limited
Active 6 years 3 months Kartik Sahay and Bharti Sahay are mutual person
All Serve Healthcare Private Limited
Active 17 years 7 months Kartik Sahay and Bharti Sahay are mutual person
Sahay Development And Exim Private Limited
Active 11 years 3 months Kartik Sahay and Bharti Sahay are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aci Pharma?
Unlock and access historical data on people associated with Aci Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aci Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aci Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
